In our cohort of 224 PD-1/PD-L1 inhibitor–related PNS cases, central nervous system presentations—such as encephalomyelitis, limbic encephalitis, and subacute cerebellar degeneration—were more frequent than peripheral neuropathies, neuromuscular junction disorders, or myopathies. This evidence concerns the gene PDCD1 and myopathy.